Downloads: 2 | Views: 171 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1
Research Paper | Ophthalmology | India | Volume 12 Issue 9, September 2023 | Popularity: 5.1 / 10
Effects of Intravitreal Injection Bevacizumab in Posterior Segment Vasculopathies - A Clinical Study
Dr. Abhiraj Mane, Dr. V. H. Karambelkar, Dr. Girish Gadre, Dr. Sanvedya Kadam
Abstract: Aim: The aimwas to study effects of intravitreal anti - vascular endothelial growth factor injection Avastin in posterior segment vasculopathies. Methods: In this prospective, single centre study, 79 eyes, including bilateral cases in age group 61 - 70 years of different posterior segment vasculopathies were given bevacizumab with dose of 1.25mg/0.05ml. post - operative vision was assessed, and OCT was done immediately and on follow up after 1 week, 4weeks. Results: Out of 79 eyes with age group 61 - 70 years, 58.67% of subjects were male and 34.67% of them were females respectively, majority were with PDR (28%) followed by BRVO (26%), CNVM (24%), CRVO (12%), ROP (6.67%), NG (1.33%) and wetARMD (1.33%) out of which there were 9 bilateral cases, 5 cases belong to PDR and intravitreal injection bilaterally was required while there were 4 bilateral active CNVM cases. majority of subjects had hypertension (41.42%) and diabetes mellitus (41.42%). Out of 5 babies 1 baby had respiratory distress. Majority of subjects had IOP 10 - 21 mm of Hg in right eye (97.14%) and left eye (92.86%) and majority of subjects had visual acuity <6/60 in right eye (58.57%) and left eye (51.43%). pre - injection. Pre - op mean OCT among subjects was 419.61. Post injection, 6/6 vision was achieved by 15 (18.99%) subjects 4 weeks later after injection AVASTIN, 19 Eyes required 2 doses of injection in CNVM (6.32%), followed by BRVO (5.06%), CRVO (2.53%), STBRVO (2.53%), ITBRVO (1.26%). Mean central macular thickness on OCT was 418.58, 333.21 and 304.32 at immediate, 1 week later and 4 week later after injection AVASTIN respectively. Conclusions: The present clinical prospective study undertaken to study effects of intravitreal anti VEGF injection Avastin in posterior segment vasculopathies concludes that Intravitreal bevacizumab application provides significant improvement in visual acuity of various posterior segment vasculopathies and may therefore be a promising approach in the primary treatment of posterior segment vasculopathies.
Keywords: Retinopathy, vasculopathy, bevacizumab, vascular endothelial growth factor
Edition: Volume 12 Issue 9, September 2023
Pages: 752 - 756
DOI: https://www.doi.org/10.21275/SR23905161226
Make Sure to Disable the Pop-Up Blocker of Web Browser
Similar Articles
Downloads: 1
Research Paper, Ophthalmology, India, Volume 10 Issue 7, July 2021
Pages: 1446 - 1449Contrast Sensitivity and Macular Thickness in Patients with Diabetic Macular Odema Following Grid Laser Photocoagulation
Porandla Laxmi Prasanna, Raghu V, Anil Kumar Bhupally, SinduSulekha Chigiri
Downloads: 1 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1
Research Paper, Ophthalmology, India, Volume 12 Issue 4, April 2023
Pages: 1022 - 1024Prevalence and Risk Factors of Primary Glaucoma in Diabetics: A Hospital based Cross Sectional Study
Manisha Chandrakant Dake, Bhavishya Gurudasani, U. C. Tiwari
Downloads: 1 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1
Research Paper, Ophthalmology, India, Volume 12 Issue 5, May 2023
Pages: 427 - 431Assessing Various Ocular Manifestions among Patients with Type-2 Diabetes Mellitus in a Tertiary Care Hospital of North India: A Cross-Sectional Study
Dr. Deepti, Dr. Gaurav Sharma, Dr. Rajeev Tuli, Dr. Vivek Sood, Dr Shweta Kanwal
Downloads: 1 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1
Research Paper, Ophthalmology, India, Volume 12 Issue 5, May 2023
Pages: 796 - 799Correlation of Visual Acuity with Diabetic Macular Edema and its Subtypes in Type 2 Diabetes Mellitus Patients
Dr. Vidyashree, Dr. Shashidhar S, Dr. Ravi B, Dr. Aswathi Muraleedharan
Downloads: 1 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1
Case Studies, Ophthalmology, India, Volume 13 Issue 12, December 2024
Pages: 1784 - 1787A Case Report of Fundus Changes in Preeclampsia
Dr. Ganesh Sathyamurthy, Dr. Amulya P., Dr. Gogula Mounika Kumari, Dr. Monisha Chowdary